Healthcare of Ontario Pension Plan Trust Fund Purchases Shares of 48,348 Aspen Aerogels, Inc. (NYSE:ASPN)

Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 48,348 shares of the construction company’s stock, valued at approximately $851,000. Healthcare of Ontario Pension Plan Trust Fund owned 0.06% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Mesirow Institutional Investment Management Inc. acquired a new position in Aspen Aerogels in the fourth quarter valued at approximately $12,015,000. Federated Hermes Inc. boosted its holdings in shares of Aspen Aerogels by 53.9% in the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock valued at $18,211,000 after buying an additional 404,042 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Aspen Aerogels by 5.1% in the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after buying an additional 175,906 shares during the last quarter. Jackson Creek Investment Advisors LLC acquired a new stake in Aspen Aerogels during the 4th quarter worth $1,598,000. Finally, Semanteon Capital Management LP purchased a new stake in Aspen Aerogels in the fourth quarter valued at $1,211,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Canaccord Genuity Group boosted their price objective on Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. Craig Hallum raised their price objective on shares of Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a research report on Friday, June 14th. HC Wainwright boosted their target price on shares of Aspen Aerogels from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday, May 3rd. Piper Sandler upped their price target on Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, May 29th. Finally, TD Cowen upped their target price on Aspen Aerogels from $30.00 to $36.00 and gave the company a “buy” rating in a report on Wednesday, June 5th. One analyst has rated the stock with a sell rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $30.75.

Read Our Latest Report on ASPN

Aspen Aerogels Price Performance

Shares of NYSE:ASPN opened at $21.63 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 3.29 and a current ratio of 4.01. The stock’s fifty day simple moving average is $26.87 and its 200-day simple moving average is $20.06. Aspen Aerogels, Inc. has a 52-week low of $5.32 and a 52-week high of $31.74.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.14. The firm had revenue of $94.50 million for the quarter, compared to analyst estimates of $73.04 million. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. On average, research analysts predict that Aspen Aerogels, Inc. will post 0.18 EPS for the current year.

Insider Transactions at Aspen Aerogels

In related news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $23.50, for a total value of $82,250,000.00. Following the sale, the insider now directly owns 12,280,426 shares of the company’s stock, valued at $288,590,011. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the firm’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $23.50, for a total value of $82,250,000.00. Following the transaction, the insider now directly owns 12,280,426 shares in the company, valued at approximately $288,590,011. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Corby C. Whitaker sold 55,159 shares of the stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares of the company’s stock, valued at approximately $3,289,640.33. The disclosure for this sale can be found here. Insiders have sold 3,832,103 shares of company stock worth $91,679,369 over the last quarter. 4.30% of the stock is currently owned by insiders.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.